Followers | 4 |
Posts | 863 |
Boards Moderated | 0 |
Alias Born | 02/10/2016 |
Wednesday, May 24, 2017 12:05:40 PM
They never even made a panel to test it because that would have proved the whole project was bunk. Making a test panel, which would have given them huge information about the potential cost and viability of the project, would not have been prohibitively expensive.
Yet it was never done.
All of the data they presented about costs and output were based on their own computer models and not an actual test product.
This means one of two things:
1. It was a scam from the beginning.
2. They knew many years ago that there were serious problems with the viability of the cell, yet declined to share that until a few weeks ago.
They would continue to say they were "close" and convinced investors that it was still viable.
The never updated corresponding information showed that the cell was supposed to be MUCH more efficient than current cells, and have the possibility to "upturn the economics of energy". If they truly believed those things then their course of action makes no sense, if you assume they were being honest.
I recall seeing a few hardcore investors on an alternate discussion board being quite surprised by the announcement in the the annual report.
Furthermore during the time between when they stopped making ANY progress and they cancelled the project they:
1. Raised capital based on it
2. Touted it at many investor conferences
3. Included it on their presentations
4. Said nothing was wrong when asked about it on the conference call
Overall it's just was just huge lie that was told to investors that ended up ripping off a lot of people from their money. Even if it wasn't a scam from the beginning, which I think it was, then nothing can excuse their actions from 2014-2017 where they continued to tout a dead product.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM